Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

Corporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...

Nine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...

Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...

At a time when the markets are focused on war, crude oil, inflation, and supply disruption, it is easy to miss a quieter shift. India’s eng...

Nayana Vaidya built Om Sai Surgicals from a modest beginning. Her company achieved a turnover of nearly ₹48 crore. Vaidya finds satisfactio...

Indian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...

Novartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...

India must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...

A major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Aurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 each. This tende...

The deal may dispel government concerns that allowing overseas investment in pharmaceutical companies would lead to a multinational monopol...

Indian as well as multinational pharmaceutical companies are likely to create more jobs in 2014 on the back of expected double digit growth...

Patents appeal board has dismissed AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fightin...

India has started a diplomatic exercise to counter a 'propaganda' by multinational pharmaceutical companies against Indian generics or off-...